INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Zydus Lifesciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532321	ISIN Demat INE010B01027	Book Value 177.87	NSE Symbol ZYDUSLIFE	Dividend Yield (%) 0.35	Market Cap (₹ Cr.) 87,366.27	P/E 19.98	EPS 43.46	Face Value 1

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	10,818.70	8,731.60	7,836.90	7,780.00	6,347.40
Sale of Products	10,317.60	8,421.20	7,590.00	7,436.70	5,967.70
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	501.10	310.40	246.90	343.30	379.70
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	10,818.70	8,731.60	7,836.90	7,780.00	6,347.40
Other Income	1,084.80	548.40	178.70	89.30	849.40
Total Revenue	11,903.50	9,280.00	8,015.60	7,869.30	7,196.80
Changes in Inventories	-131.70	105.10	-46.90	-148.30	15.50
Cost of Material Consumed	3,001.40	2,703.50	2,629.00	2,346.40	1,838.30
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	283.20	362.70	288.10	153.30	97.90
Employee Benefits	1,507.50	1,321.90	1,204.90	1,147.30	1,077.40
Total Other Expenses	2,099.60	1,784.00	1,843.70	1,972.60	1,895.20
Manufacturing / Operating Expenses	645.40	611.10	626.30	556.60	535.70
Administrative and Selling Expenses	1,016.00	1,039.80	958.40	1,009.10	925.30
Other Expenses	438.20	133.10	259.00	406.90	434.20
Finance Costs	390.70	278.20	134.90	70.90	233.90
Depreciation and Amortization	504.40	488.60	478.70	451.10	428.90
Total Expenses	7,655.10	7,044.00	6,532.40	5,993.30	5,587.10
Profit Before Exceptional Items and Tax	4,248.40	2,236.00	1,483.20	1,876.00	1,609.70
Exceptional Items Before Tax	-8.60	-203.80	-319.30	-187.50	-52.00
Profit Before Extraordinary Items and Tax	4,239.80	2,032.20	1,163.90	1,688.50	1,557.70
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	4,239.80	2,032.20	1,163.90	1,688.50	1,557.70
Taxation	798.30	503.00	306.00	212.30	204.10
Current Tax	934.30	464.10	260.20	303.20	164.60
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-136.00	41.20	45.80	-91.00	40.00
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	-2.30	0.00	0.10	-0.50
Profit After Tax	3,441.50	1,529.20	857.90	1,476.20	1,353.60
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	59.30
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	68.20
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	-8.90
Profit Attributable to Shareholders	3,441.50	1,529.20	857.90	1,476.20	1,412.90
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	3,441.50	1,529.20	857.90	1,476.20	1,412.90
Earning Per Share - Basic	34.01	15.06	8.38	14.42	13.80
Earning Per Share - Diluted	34.01	15.06	8.38	14.42	13.80
Operation Profit before Depreciation	5,143.50	3,002.80	2,096.80	2,398.00	2,272.50
Operating Profit after Depreciation	4,639.10	2,514.20	1,618.10	1,946.90	1,843.60
Dividend Per Share	3.00	6.00	2.50	3.50	3.50
Dividend Percentage	300.00	600.00	250.00	350.00	350.00
Equity Dividend	301.87	607.32	255.94	358.31	358.31
Weighted Average Shares - Basic	101.19	101.56	102.37	102.37	102.37
Weighted Average Shares - Diluted	101.19	101.56	102.37	102.37	102.37